LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Net income, 2025
- $124M
- 10-year CAGR
- −5.9%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $124M | — |
| 2024 | −$4.0M | — |
| 2023 | $52M | — |
| 2022 | −$33M | — |
| 2021 | $57M | — |
| 2020 | −$3.0M | — |
| 2019 | $629M | +339.1% |
| 2018 | $143M | +1,041.5% |
| 2017 | $13M | — |
| 2016 | −$1.6M | — |
| 2015 | $230M | +1,811.4% |
| 2014 | $12M | +5.3% |
| 2013 | $11M | — |
| 2012 | −$527K | — |
| 2011 | $9.7M | — |
| 2010 | −$10M | — |
| 2009 | −$1.9M | — |